SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Drugs board to consider third interim dividend

10 Mar 2016 Evaluate

Aarti Drugs has informed that a meeting of the Board of Directors of the Company will be held on March 16, 2016, to consider declaration of 3rd Interim Dividend for the financial year 2015-16, if any. In accordance with Code of Conduct for Prevention of Insider Trading framed by the Company pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in the securities of the Company will be closed for all Directors and designated employees of the Company from March 10, 2016 to March 18, 2016.

The above information is a part of company’s filings submitted to BSE.

Aarti Drugs Share Price

373.15 5.15 (1.40%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×